These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38426303)

  • 1. Two-electron oxidized polyphenol chemistry-inspired superhydrophilic drug-carrying coatings for the construction of multifunctional nasolacrimal duct stents.
    Xiao W; Wang B; Wang X; Zhang G; Zhao Y; Zhang Z; Li L; Qu C
    J Mater Chem B; 2024 Mar; 12(11):2877-2893. PubMed ID: 38426303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Annular electrode lacrimal duct reconstruction for improving the safety and efficacy of lacrimal stent implantation: a randomized clinical trial].
    Hu W; Guo H; Liao H; Huang X
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jan; 36(1):13-9. PubMed ID: 26806732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasolacrimal stent with shape memory as an advanced alternative to silicone products.
    Park JY; Lee JB; Shin WB; Kang ML; Shin YC; Son DH; Yi SW; Yoon JK; Kim JY; Ko J; Kim CS; Yoon JS; Sung HJ
    Acta Biomater; 2020 Jan; 101():273-284. PubMed ID: 31707084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of monocanalicular stenting and balloon dacryoplasty in secondary treatment of congenital nasolacrimal duct obstruction after failed primary probing.
    Goldstein SM; Goldstein JB; Katowitz JA
    Ophthalmic Plast Reconstr Surg; 2004 Sep; 20(5):352-7. PubMed ID: 15377901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of nasolacrimal duct obstruction in adults with polyurethane stent.
    Yazici B; Yazici Z; Parlak M
    Am J Ophthalmol; 2001 Jan; 131(1):37-43. PubMed ID: 11162977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The polyurethane nasolacrimal duct stent for lower tear duct obstruction: long-term success rate and complications.
    Schaudig U; Maas R
    Graefes Arch Clin Exp Ophthalmol; 2000 Sep; 238(9):733-7. PubMed ID: 11045340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic-assisted retrieval of retained lacrimal stent material in congenital nasolacrimal duct obstruction without dacryocystorhinostomy.
    Ng DS; Chan E; Tong FM; Chow SK; Ko ST
    Orbit; 2016; 35(2):103-5. PubMed ID: 26838355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insertion of a preloaded Monoka™ stent for congenital nasolacrimal obstruction: Intraoperative observations. A preliminary study.
    Fayet B; Racy E; Katowitz J; Katowitz W; Ruban JM; Brémond-Gignac D
    J Fr Ophtalmol; 2019 Mar; 42(3):248-254. PubMed ID: 30871792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic findings after nasolacrimal polyurethane stent implantations.
    Lee JH; Kang MS; Yang JW
    Korean J Ophthalmol; 2005 Dec; 19(4):252-7. PubMed ID: 16491813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of patients with nasolacrimal polyurethane stent implantation: do they keep tearing?
    Oztürk S; Konuk O; Ilgit ET; Unal M; Erdem O
    Ophthalmic Plast Reconstr Surg; 2004 Mar; 20(2):130-5. PubMed ID: 15083082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nasolacrimal stent implantation: report of a case].
    Lunardelli P; Aoki L; Jervásio AC; Zagui RM; Matayoshi S
    Arq Bras Oftalmol; 2008; 71(1):110-4. PubMed ID: 18408851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nasolacrimal stent for epiphora caused by obstruction of the nasolacrimal duct].
    Posthuma BJ; van Imhoff WL; van Wezer JE
    Ned Tijdschr Geneeskd; 1997 Feb; 141(7):339-41. PubMed ID: 9132609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A comparative study of lacrimal magnetic resonance hydrography and lacrimal endoscopy examination in the diagnosis and treatment of lacrimal duct obstructive diseases].
    Xiang N; Liu R; Zhang SJ; Hu WK; Zhan XY; Luo B; Ai T
    Zhonghua Yan Ke Za Zhi; 2016 Feb; 52(2):117-22. PubMed ID: 26906707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Passivation protein-adhesion platform promoting stent reendothelialization using two-electron-assisted oxidation of polyphenols.
    Li L; Zhang C; Cao Z; Ma L; Liu C; Lan X; Qu C; Fu P; Luo R; Wang Y
    Biomaterials; 2024 Mar; 305():122423. PubMed ID: 38142470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasolacrimal duct obstruction as an important cause of epiphora.
    Avdagic E; Phelps PO
    Dis Mon; 2020 Oct; 66(10):101043. PubMed ID: 32622678
    [No Abstract]   [Full Text] [Related]  

  • 16. Probing for congenital nasolacrimal duct obstruction.
    Petris C; Liu D
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011109. PubMed ID: 28700811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: "intubation of the ostium and nasolacrimal duct with a single self-linking silicone stent in external dacryocystorhinostomy".
    Nakra T; Blaydon S; Shepler T; Nasser QJ; Mukhopadhyay C; Shinder R
    Ophthalmic Plast Reconstr Surg; 2011; 27(5):394; author reply 395. PubMed ID: 21904180
    [No Abstract]   [Full Text] [Related]  

  • 18. Re:"intubation of the ostium and nasolacrimal duct with a single self-linking silicone stent in external dacryocystorhinostomy".
    Nieto J
    Ophthalmic Plast Reconstr Surg; 2011; 27(5):394-5; author reply 395-6. PubMed ID: 21904179
    [No Abstract]   [Full Text] [Related]  

  • 19. Complex Bony Congenital Nasolacrimal Duct Obstruction Caused by an Adjacent Canine Tooth Bud.
    Fayet B; Racy E; Bordonné C; Katowitz WR; Katowitz J; Brémond-Gignac D
    Ophthalmic Plast Reconstr Surg; 2019; 35(1):e23-e24. PubMed ID: 30614950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy of the polyurethane stent without fluoroscopic guidance in the treatment of nasolacrimal duct obstruction.
    Lee JS; Jung G; Oum BS; Lee SH; Roh HJ
    Ophthalmology; 2000 Sep; 107(9):1666-70. PubMed ID: 10964826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.